Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F B Wright

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
British Journal of Clinical Pharmacology|October 4, 2018
Response to 'Comment on ''Massive' metformin overdose' by Chiew et al.'Angela L Chiew, Daniel F B Wright, Michael S Roberts, et al.
The AAPS Journal|August 7, 2019
Evaluation of Assumptions Underpinning Pharmacometric ModelsQing-Xi Ooi, Daniel F B Wright, Geoffrey K Isbister, et al.
British Journal of Clinical Pharmacology|January 21, 2025
Risk of bias tools for medication adherence research: RoBIAS and RoBOASKlarissa A Sinnappah, Dyfrig A Hughes, Sophie L Stocker, et al.
Therapeutic Drug Monitoring|December 31, 2014
Methods for Predicting Warfarin Dose RequirementsShamin M Saffian, Daniel F B Wright, Rebecca L Roberts, et al.
Research in Social & Administrative Pharmacy : RSAP|May 6, 2017
A philosophical framework for pharmacy in the 21st century guided by ethical principlesStephen B Duffull, Daniel F B Wright, Carlo A Marra, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 15, 2017
Deterministic identifiability of population pharmacokinetic and pharmacokinetic-pharmacodynamic modelsVijay K Siripuram, Daniel F B Wright, Murray L Barclay, et al.
Scientific Reports|August 15, 2018
A factor VII-based method for the prediction of anticoagulant response to warfarinQing-Xi Ooi, Daniel F B Wright, Geoffrey K Isbister, et al.
British Journal of Clinical Pharmacology|June 11, 2020
Understanding the association between metformin plasma concentrations and lactateIsabelle H S Kuan, Daniel F B Wright, Stephen B Duffull, et al.
British Journal of Clinical Pharmacology|February 25, 2025
Alternative splicing with CYP3A4*22: Implications for the steroid-tacrolimus drug interactionJana Stojanova, Nuala Ann Helsby, Daniel F B Wright, et al.
Journal of the American College of Cardiology|April 1, 2014
Learning more from the dabigatran concentrations in the RE-LY studyPaul K L Chin, Daniel F B Wright, Matthew P Doogue, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
British Journal of Clinical Pharmacology|October 4, 2018
Response to 'Comment on ''Massive' metformin overdose' by Chiew et al.'Angela L Chiew, Daniel F B Wright, Michael S Roberts, et al.
The AAPS Journal|August 7, 2019
Evaluation of Assumptions Underpinning Pharmacometric ModelsQing-Xi Ooi, Daniel F B Wright, Geoffrey K Isbister, et al.
British Journal of Clinical Pharmacology|January 21, 2025
Risk of bias tools for medication adherence research: RoBIAS and RoBOASKlarissa A Sinnappah, Dyfrig A Hughes, Sophie L Stocker, et al.
Therapeutic Drug Monitoring|December 31, 2014
Methods for Predicting Warfarin Dose RequirementsShamin M Saffian, Daniel F B Wright, Rebecca L Roberts, et al.
Research in Social & Administrative Pharmacy : RSAP|May 6, 2017
A philosophical framework for pharmacy in the 21st century guided by ethical principlesStephen B Duffull, Daniel F B Wright, Carlo A Marra, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 15, 2017
Deterministic identifiability of population pharmacokinetic and pharmacokinetic-pharmacodynamic modelsVijay K Siripuram, Daniel F B Wright, Murray L Barclay, et al.
Scientific Reports|August 15, 2018
A factor VII-based method for the prediction of anticoagulant response to warfarinQing-Xi Ooi, Daniel F B Wright, Geoffrey K Isbister, et al.
British Journal of Clinical Pharmacology|June 11, 2020
Understanding the association between metformin plasma concentrations and lactateIsabelle H S Kuan, Daniel F B Wright, Stephen B Duffull, et al.
British Journal of Clinical Pharmacology|February 25, 2025
Alternative splicing with CYP3A4*22: Implications for the steroid-tacrolimus drug interactionJana Stojanova, Nuala Ann Helsby, Daniel F B Wright, et al.
Journal of the American College of Cardiology|April 1, 2014
Learning more from the dabigatran concentrations in the RE-LY studyPaul K L Chin, Daniel F B Wright, Matthew P Doogue, et al.
Pageof 9